IDT and Ansa Biotechnologies join forces to push limits of DNA synthesis
The collaboration aims to accelerate the delivery of challenging DNA motifs with speed, precision, and reliability
The collaboration aims to accelerate the delivery of challenging DNA motifs with speed, precision, and reliability
The expanded agreement significantly widens the scope of integrated services across the entire drug development lifecycle
The randomized, double-blind, placebo-controlled Phase 2b VITAL trial enrolled 91 patients with newly diagnosed Stage IIIb–IV epithelial ovarian cancer
GCCL aims to leverage the partnership to expand strategic relationships with global CROs
The feature will be available across all Max Healthcare facilities, offering patients consistent and convenient access to services nationwide
The BD Neopak Glass Prefillable Syringe platform is designed for the complex needs of biologics and combination products
Artificial intelligence coupled with laboratory automation will transform how scientific work is performed
The deal brings Labcorp’s U.S. portfolio—including biocompatibility, microbiological, and analytical testing, as well as preclinical research—under NAMSA’s roof
The multimillion-dollar facility combines discovery and early-phase scale-up capabilities with R&D labs and two pilot plants
Subscribe To Our Newsletter & Stay Updated